Products for Research Use Only
RegisterLogin

PDS-MMAE

CAT: 0804-HY-153958-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-153958-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PDS-MMAE (Compound 5’) is a modified MMAE. PDS-MMAE can be used for preparation of neurotensin receptor binding conjugates[1].
CAS Number
1613113-44-2
UNSPSC
12352203
Target
Drug-Linker Conjugates for ADC
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pds-mmae.html
Purity
99.76
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C[C@@H](C(N[C@H](C)[C@H](C1=CC=CC=C1)O)=O)[C@H]([C@@](CCC2)([H])N2C(C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C([C@H](C(C)C)NC([C@H](C(C)C)N(C)C(OCCSSC3=CC=CC=N3)=O)=O)=O)=O)OC
Molecular Formula
C47H74N6O9S2
Molecular Weight
931.26
References & Citations
[1]Mark T. Bilodeau, et al. Neurotensin receptor binding conjugates and formulations thereof. Patent. WO2017180834.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
ADC Related
Clinical Information
No Development Reported

Related Products

CatalogName
HY-153833-01PDS-0330
HY-128896Nitro-PDS-Tubulysin M
HY-171572-01Atezolizumab-MMAE
HY-171269Anetumab-MMAE
HY-171135-01Cetuximab MMAE
HY-156712-01Depatuxizumab MMAE
HY-78933-01Fmoc-MMAE
HY-171270-01Clivatuzumab-MMAE
HY-15741-01Mc-MMAE
HY-15162A-01MMAE-d8

Alternative Products

CatalogName
BA2683-10PDS-MMAE
GTR19216161-01PDS-0330
GTR18002083PDS Antibody
BIBE1010PDS Homopolymer
P53952PBTK562 (pDS-GFP)
513258PTGDS (PDS) discontinued
287430Poly (dioxanone) (PDS)

Popular Products